Tacrolimus-d3

CAT:
804-HY-13756S2
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tacrolimus-d3 - image 1

Tacrolimus-d3

  • Description :

    Tacrolimus-d3 (FK506-d3) is deuterium labeled Tacrolimus. Tacrolimus (FK506), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex. Tacrolimus inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].
  • Product Name Alternative :

    FK506-d3; Fujimycin-d3; FR900506-d3
  • UNSPSC :

    12352005
  • Target :

    Antibiotic; Autophagy; Bacterial; FKBP; Isotope-Labeled Compounds; Phosphatase
  • Related Pathways :

    Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Others
  • Applications :

    COVID-19-anti-virus
  • Field of Research :

    Cancer; Infection; Inflammation/Immunology
  • Smiles :

    O=C([C@@](CCCC1)([H])N1C(C([C@@]2(O)[C@H](C)C[C@H](OC)[C@@](O2)([H])[C@@H](OC)C[C@@H](C)C/C(C)=C/C3([2H])CC=C)=O)=O)O[C@H](/C(C)=C/[C@H]4C[C@@H](OC)[C@H](O)CC4)[C@H](C)[C@@H](O)C([2H])([2H])C3=O
  • Molecular Formula :

    C44H66D3NO12
  • Molecular Weight :

    807.04
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Thomson AW, et al. Mode of action of Tacrolimus (FK506) : molecular and cellular mechanisms. Ther Drug Monit. 1995 Dec;17 (6) :584-91.|[3]Vogel KR, et al. mTOR inhibitors rescue premature lethality and attenuate dysregulation of GABAergic/glutamatergic transcription in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism. J Inherit Metab Dis. 2016 Nov;39 (6) :877-886.|[4]Zhu H, et al. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF 1α expression in vivo. Mol Med Rep. 2014 Aug;10 (2) :585-92.|[5]Okada Y, et al. Tacrolimus ameliorates dextran sulfate sodium-induced colitis in mice: implication of interleukin-1β suppression. Biol Pharm Bull. 2011;34 (12) :1823-7.|[6]Yuwei He, et al. Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis. Nano Res. 30 June 2018.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide